Skip to main content
INOVIQ LTD logo

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Filings indexed 858 across all filing types
Latest filing 2018-12-17 Director's Dealing
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
Change of Directors Interest - Irminger-Finger 2 pages 209.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details the change in securities held by a director, including the number of shares before and after the change, the nature of the interest, and the value of the transaction. This is a clear report of personal share transactions by a company director. The document length is 3480 characters, which is typical for such notices. There is no indication that this is a full financial report or an announcement of a report. Therefore, the document fits the definition of 'Director's Dealing' (DIRS).
2018-12-17 English
Change in Substantial Holding 2 pages 79.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, Section 671B, which is a Notice of change of interests of a substantial shareholder. It details changes in voting power and shareholdings of Dr. Irmgard Irminger-Finger in Bard1 Life Sciences Limited, including dates and nature of transactions. This type of filing corresponds to notifications about major shareholding changes, not a financial report or other corporate filings. The document length is 4411 characters, which is consistent with a detailed substantial shareholder notice. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2018-12-17 English
Closure of Entitlement Offer and Shortfall 1 page 9
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the closure of an entitlement offer and notification of shortfall in subscription for new shares. It details the amount raised, the number of shares subscribed, and mentions a mandate letter with a corporate advisory firm for placing shortfall shares. There is no financial report, detailed financial statements, or management discussion of results. The document is focused on fundraising activity and capital structure changes. The document length is short (2291 characters), and it is clearly an update on financing activity rather than a full report or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-12-11 English
Change of Director's Interest Notice 3 pages 275.8KB
Director's Dealing Classification · 100% confidence The document is an Appendix 3Y filing, which is a Change of Director's Interest Notice. It details the sale of shares by an executive director, including the number of shares sold, dates, and consideration. This type of document reports personal share transactions by company directors and executives, which fits the definition of Director's Dealing filings. The document is not a full financial report, earnings release, or any other type of report but a regulatory disclosure of insider trading activity.
2018-12-02 English
AGM Presentation 26 pages 746.7KB
AGM Information Classification · 95% confidence The document text includes an agenda for an Annual General Meeting (AGM) with items such as Chairman's opening, business of meeting including resolutions, CEO presentation, and questions. It specifically mentions the tabling and consideration of the 2018 Annual Report including the Financial Report, Directors’ Report, and Auditors’ Report for the period 1 July 2017 to 30 June 2018. There are also resolutions related to the adoption of the Remuneration Report and re-election of a director, which are typical AGM agenda items. The document contains detailed presentation slides and information that would be shared during an AGM, including business updates, financial highlights, and shareholder information. The presence of the CEO presentation and the business of meeting agenda confirms this is material prepared for the AGM event itself rather than the Annual Report or other filings. Therefore, the document is best classified as AGM Information (AGM-R). The document length (15,000 characters) and content support this classification with high confidence.
2018-11-29 English
Results of Meeting 1 page 133.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and provides detailed voting results for resolutions passed at the AGM of BARD1 Life Sciences Limited. It includes vote counts for each resolution and confirms that all resolutions were carried. The content is focused on the official announcement of voting outcomes from the AGM, not the AGM materials or presentations themselves. The document length is short (2249 characters), and it does not contain financial statements or detailed report content. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.